Synapse

← JACC Asia

Papers in JACC Asia

Page 12 · newest first

  1. Risk Factors and Prevention Strategies for Gestational Diabetes in Asian PopulationsJACC Asia · 2024
  2. Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic StenosisJACC Asia · 2024
  3. Systolic Blood Pressure Time in Target Range and Cardiovascular Disease and Premature DeathJACC Asia · 2024
  4. Supranormal Left Ventricular Ejection Fraction, Concentric Remodeling, and Long-Term SurvivalJACC Asia · 2024
  5. Predicting Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction by Using Machine LearningJACC Asia · 2024
  6. Catheter Ablation for Ventricular Tachycardia in Patients With Biopsy-Proven MyocarditisJACC Asia · 2024
  7. Myocardial Abnormalities Across the AHA/ACC Stages of Heart Failure in Patients With DiabetesJACC Asia · 2024
  8. Right Ventricular Restrictive Physiology Is Associated With Right Ventricular Direct Flow From 4D Flow CMRJACC Asia · 2024
  9. EXPANDing in JapanJACC Asia · 2024
  10. Update on Prosthesis–Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian PatientsJACC Asia · 2024
  11. Impact of Educational Intervention on Anticoagulation Control Using SAMe-TT22R2 Score-Guided Strategy in Atrial FibrillationJACC Asia · 2024
  12. 1-Year Clinical Outcomes and the Impact of Procedural Configurations in Left Atrial Appendage Occlusion PatientsJACC Asia · 2024
  13. 1-Year Outcomes of Fourth-Generation Mitral Transcatheter Edge-to-Edge Repair in Japan From the EXPAND G4 StudyJACC Asia · 2024
  14. How Early Is Early?JACC Asia · 2024
  15. Early Cryoablation After First Diagnosis of Atrial Fibrillation Reduces Arrhythmia Recurrence in Heart Failure PatientsJACC Asia · 2024
  16. Association of Prepregnancy Cardiometabolic Factors With Gestational Diabetes Among Asian Populations in the United StatesJACC Asia · 2024
  17. Risk Stratification With Fractional Flow Reserve and Fractional Flow Reserve Gradient From CCTAJACC Asia · 2024
  18. Lp(a) and Accelerated Progression of Aortic StenosisJACC Asia · 2024
  19. Translational Research and Clinical Application of Traditional Chinese Medicine in Cardiovascular DiseasesJACC Asia · 2024
  20. Diversity in Acute PericarditisJACC Asia · 2024
  21. Association of Lipoprotein(a) With Severe Degenerative Aortic Valve StenosisJACC Asia · 2024
  22. Clinical Characteristics, Outcomes, and Risk Stratification of Combined Mitral and Tricuspid RegurgitationJACC Asia · 2024
  23. Genetic Associations of Lipids and Lipid-Modifying Drug Targets With Type 2 Diabetes in the Chinese PopulationJACC Asia · 2024
  24. Expectations for MIRACLE-AFJACC Asia · 2024
  25. Diversity in Acute Autoimmune PericarditisJACC Asia · 2024
  26. Fractional Flow Reserve and Fractional Flow Reserve Gradient From CCTA for Predicting Future Coronary EventsJACC Asia · 2024
  27. Gender Disparities in Japanese Interventional CardiologyJACC Asia · 2024
  28. Widespread Use of Imaging-Guided PCI in AsiaJACC Asia · 2024
  29. Bidirectional Associations Between Cardiometabolic Multimorbidity and Depression and Mediation of LifestylesJACC Asia · 2024
  30. Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary HypertensionJACC Asia · 2024
  31. Transcatheter Aortic Valve Implantation in Japanese Patients With Large AnnulusJACC Asia · 2024
  32. Angioplasty for Chronic Thromboembolic Pulmonary HypertensionJACC Asia · 2024
  33. Homocysteine and Myocardial InjuryJACC Asia · 2024
  34. A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural ChinaJACC Asia · 2024
  35. Mortality, Cardiovascular Disease, and Their Associations With Risk Factors in Southeast AsiaJACC Asia · 2024
  36. Outcomes of Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty and Pulmonary EndarterectomyJACC Asia · 2024
  37. Residual Inflammatory Risk in Outcomes of Chinese Patients After Percutaneous Coronary InterventionJACC Asia · 2024
  38. New Era of Measurable Surgical Risk Predictor by 3D Quantitative CT on Pulmonary Venous ReturnJACC Asia · 2024
  39. Homocysteine Metabolism, Subclinical Myocardial Injury, and Cardiovascular Mortality in the General PopulationJACC Asia · 2024
  40. Quantification of 3-Dimensional Confluence-Atrial Morphology in Supracardiac Total Anomalous Pulmonary Venous ConnectionJACC Asia · 2024
  41. Phenotypic Characteristics of Acute Decompensated Heart Failure With Preserved Ejection Fraction in Japanese PopulationJACC Asia · 2024
  42. Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary InterventionJACC Asia · 2024
  43. Initial Results of Intra-Annular Self-Expandable ValvesJACC Asia · 2024
  44. No Standard Risk Factors Is the Marker for Clinical Outcomes in Patients With Myocardial InfarctionJACC Asia · 2024
  45. Refining the Cardiovascular Health Score in Patients With Type 2 DiabetesJACC Asia · 2024
  46. Benefit of Earlier Intervention for Degenerative Mitral Regurgitation in Asian PatientsJACC Asia · 2024
  47. Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial InfarctionJACC Asia · 2024
  48. Management of Coronary Vulnerable Plaque With Medical Therapy or Local Preventive Percutaneous Coronary InterventionJACC Asia · 2024
  49. Life’s Essential 8 in Relation to Cardiovascular Disease and Mortality in Individuals With DiabetesJACC Asia · 2024
  50. Degenerative Mitral Regurgitation Outcomes in Asian Compared With European-American InstitutionsJACC Asia · 2024